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The transcription factors that control lineage speciﬁcation
of haematopoietic stem cells (HSCs) have been well de-
scribed for the myeloid and lymphoid lineages, whereas
transcriptional control of erythroid (E) and megakaryocy-
tic (Mk) fate is less understood. We here use conditional
removal of the GATA-1 and FOG-1 transcription factors to
identify FOG-1 as required for the formation of all com-
mitted Mk- and E-lineage progenitors, whereas GATA-1
was observed to be speciﬁcally required for E-lineage
commitment. FOG-1-deﬁcient HSCs and preMegEs, the
latter normally bipotent for the Mk and E lineages, under-
went myeloid transcriptional reprogramming, and formed
myeloid, but not erythroid and megakaryocytic cells
in vitro. These results identify FOG-1 and GATA-1 as
required for formation of bipotent Mk/E progenitors and
their E-lineage commitment, respectively, and show that
FOG-1 mediates transcriptional Mk/E programming of
HSCs as well as their subsequent Mk/E-lineage commit-
ment. Finally, C/EBPs and FOG-1 exhibited transcriptional
cross-regulation in early myelo-erythroid progenitors
making their functional antagonism a potential mechan-
ism for separation of the myeloid and Mk/E lineages.
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Introduction
Lineage speciﬁcation in the haematopoietic system is highly
regulated at the transcriptional level, and for many lineages
speciﬁc transcription factors have been identiﬁed as critical
for their speciﬁcation. Thus, formation of granulocyte-
macrophage progenitors (GMPs) is regulated by C/EBPa
during steady-state haematopoiesis (Zhang et al, 2004) and
by C/EBPb during stress granulopoiesis (Hirai et al, 2006),
whereas Pax5 and GATA-3 control B and T lymphopoiesis,
respectively (Urbanek et al, 1994; Ting et al, 1996). One
roadblock to understanding how lineage commitment occurs
in the myeloid branch of the deﬁnitive haematopoietic system
has been our limited ability to precisely identify bipotent and
monopotent progenitors with deﬁned lineage potentials. In
particular, progenitors for megakaryocytic (Mk) and ery-
throid (E) cells have remained elusive, complicating the
identiﬁcation of their specifying factors. Recently, the identi-
ﬁcation and prospective isolation of bipotent Mk/E progeni-
tors (preMegEs), unipotent Mk and E progenitors (MkP and
preCFU-E/CFU-E, respectively), as well as an early myeloid-
committed progenitor (preGM) (Pronk et al, 2007) has
opened up the possibility of studying the separation of the
GM, Mk and E lineages in greater detail.
Using distinct cell sorting strategies cell populations
containing progenitors with both Mk and E potential, but
devoid of myeloid or lymphoid potential, have been identiﬁed
(Akashi et al, 2000; Pronk et al, 2007). Therefore, the
divergence of the Mk and E lineages is the last decision
made before fully committed Mk and E progenitors arise.
Candidate lineage specifying factors are Klf1 (also known as
EKLF) and Fli-1. Klf1 is preferentially expressed in Mk/E
bipotent and E-committed progenitors, but is downregulated
in committed Mk progenitors (Frontelo et al, 2007).
Conversely, Fli-1 expression is downregulated upon E-lineage
commitment and upregulated in Mk progenitors. In murine
embryoid bodies and human CD34þ cord blood cells ectopic
Klf1 expression suppressed both Fli-1 expression and Mk
progenitor formation, whereas mutation or knockdown of
Klf1 (or its human homologue) was found to increase Mk
differentiation (Frontelo et al, 2007; Bouilloux et al, 2008).
Conversely, Fli-1 loss-of-function mutation, in both mouse
and human, caused Mk differentiation defects (Hart et al,
2000; Starck et al, 2010), whereas its overexpression pro-
moted megakaryopoiesis and suppressed erythropoiesis
(Athanasiou, 1996, 2000). Finally, Fli-1 antagonizes Klf1
activity through protein–protein interaction (Starck et al,
2003), indicating Fli-1–Klf1 cross-antagonism as a potential
mechanism for Mk–E-lineage separation. However, since Klf1
and Fli-1 deﬁciency causes defective erythroid (Nuez et al,
1995; Perkins et al, 1995) and megakaryocyte differentiation
(Hart et al, 2000; Spyropoulos et al, 2000; Starck et al, 2010),
respectively, rather than lineage commitment defects, it is
possible that the function of their antagonism is lineage
‘lockdown’, with other transcriptional regulators involved
in actual lineage speciﬁcation.
The current paradigm for separation of the GM and Mk/E
lineages states that PU.1 and GATA-1 maintain the multi-
potent state through a combination of mutual functional
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351inhibition and autoregulation (Burda et al, 2010). This
model is supported by gain-of-function studies where PU.1
expression induces myeloid-lineage commitment, and
GATA-1 induces erythroid/megakaryocytic commitment or
potential, in heterologous or multipotent cell types (Burda
et al, 2010). Conditional PU.1 deletion in the adult haemato-
poietic system prevents the formation of both the common
lymphoid progenitor (CLP) population and common myeloid
progenitor (CMP) population (which includes Mk/E-com-
mitted cells; Pronk et al, 2007) and leads to the generation
of self-renewing myeloid cell populations (Dakic et al, 2005;
Iwasaki et al, 2005), consistent with a role in early myeloid-
lineage speciﬁcation. The results of GATA-1 loss-of-function
studies are more ambiguous, since GATA-1 deletion has
not been reported to enhance myelopoiesis or impair
Mk/E-lineage commitment (Gutierrez et al, 2008). The
requirements for Mk/E-lineage commitment has therefore
remained elusive.
In addition to PU.1 also C/EBPa and C/EBPb have been
shown to mediate myeloid-lineage commitment. In the
absence of C/EBPa, GMPs are not formed during steady-
state haematopoiesis (Zhang et al, 2004), whereas C/EBPb
promotes GMP formation during stress haematopoiesis (Hirai
et al, 2006). Based on the hypothesis that mediators of Mk/
E-lineage commitment would exhibit an antagonistic rela-
tionship to C/EBPs similar to that of PU.1–GATA-1 and Klf1–
Fli-1 we examined C/EBP-deﬁcient haematopoiesis, and
found that preGMs blocked from proceeding to the GMP
stage upregulate Gata1, Gata2, Zfpm1 (encoding FOG-1),
Fli-1 and Sfpi1 (encoding PU.1). As it was previously
observed that FOG-1 was able to confer Mk/E potential on
myeloid cells in a GATA-1-dependent manner we initially
focused on these two factors. By conditionally deleting
Zfpm1 and Gata1, we observed that loss of the former
prevented speciﬁcation of all Mk/E-committed progenitors,
whereas Gata1 was required for the commitment of bipotent
preMegEs towards an erythroid fate. Therefore, FOG-1
and GATA-1 act sequentially to generate and specify Mk/E
progenitors during deﬁnitive haematopoiesis.
Results
Depletion of C/EBPs alters lineage potential and gene
expression of preGMs
Based on the hypothesis that factors promoting Mk/E and
myeloid commitment would behave antagonistically we con-
ditionally depleted C/EBP transcription factors, known to
promote myeloid progenitor formation, from the haemato-
poietic system. We generated mice carrying two ﬂoxed Cebpa
alleles and one ﬂoxed Cebpb allele, along with the Mx1-Cre
transgene (Cebpa
ﬂ/ﬂ; Cebpb
ﬂ/þ; Mx1-Cre
tg/þ: C/EBP
cKO
mice) and corresponding control mice lacking the Mx1-Cre
transgene (Cebpa
ﬂ/ﬂ; Cebpb
ﬂ/þ: C/EBP
Con mice). One Cebpb
allele was maintained as wild type since we observed that
Mx1-Cre mediated deletion of all four Cebpa and Cebpb alleles
led to rapid lethality (L Luciani and C Nerlov, unpublished).
Recombination was initiated by injection of poly(I-C), which
in the presence of Mx1-Cre leads to near-complete recombi-
nation in haematopoietic tissues (Kirstetter et al, 2006). After
12 days, the effect of C/EBP depletion was analysed by
progenitor phenotyping (Pronk et al, 2007). We observed
an overall expansion of the stem/progenitor compartment
(data not shown), consistent with results previously obtained
from Cebpa knock-in mice (Porse et al, 2005; Bereshchenko
et al, 2009), which likely reﬂect loss of cell-cycle control in
the stem cell compartment. C/EBP
cKO bone marrow stem/
progenitor cells were unable to generate GMPs, consistent
with results previously obtained for conditional Cebpa knock-
out mice (Zhang et al, 2004), while phenotypic myeloid-
committed preGM cells were formed (Figure 1A and B).
In addition, we saw a signiﬁcant increase in MkPs as a
proportion of the Lin/Sca-1/IL7Ra–c-Kitþ progenitor popu-
lation, as well as an increase in the number of Mk colony
forming cells (Figure 1C). The presence of preGM progeni-
tors, which normally show predominantly myeloid potential
(Pronk et al, 2007), in the absence of further differentiation
along the myeloid lineage, led us to investigate the gene
expression and lineage potential of these cells. Colony form-
ing assays on sorted preGMs under GM, Mk and E conditions
showed an overall decrease in clonogenic potential, but with
the proportion of CFU-Mk being increased in both relative
and absolute terms (Figure 1D). This was accompanied by
upregulation of Mk lineage-associated genes, including Mpl,
Fli1, Zfpm1, Gata1 and Gata2 (Figure 1E and F). Most of
these encode transcriptional regulators with lineage regula-
tory potential. In particular, GATA-1 and FOG-1 have pre-
viously been implicated in extinction of myeloid-lineage
programming and acquisition of Mk/E potential (Kulessa
et al, 1995; Querfurth et al, 2000). We, therefore, selected
these two factors for further study.
GATA-1 is dispensable for preMegE formation, but
required for their progression along the erythroid
lineage
Loss of GATA-1 has previously been observed to block
erythroid progenitors from terminally differentiating, but
effects on lineage speciﬁcation have not been addressed.
We generated male mice containing a ﬂoxed Gata1 allele
(in the hemizygous state, since the gene is X-linked) and the
Figure 1 C/EBP depletion expands stem/progenitor cells and activates Mk potential. (A) Representative FACS proﬁles of C/EBP
Con and
C/EBP
cKO bone marrow 12 days after poly(I-C) treatment. The top panel shows the gating strategy and gates used to deﬁne the progenitor
populations. (B) Progenitor population sizes determined as in (A) expressed as percentage of the Lin/Sca-1/IL7Ra–c-Kitþ fraction for
C/EBP
Con (n¼4) and C/EBP
cKO (n¼5) mice. (C) Total C/EBP
Con and C/EBP
cKO bone marrow cells were plated in MegaCult assays, and the
number of Mk colonies determined. Each measurement was performed in quadruplicate. Error bars indicate standard deviations (**Po0.01;
Student’s t-test). (D) Lineage potential of C/EBP
Con and C/EBP
cKO preGM cells was assayed separately under GM (M3534), E (M3436) and Mk
(MegaCult) conditions. In the case of GM conditions, colonies with immature blast morphology (blasts) are shown separately from normal GM
colonies. The average number of colony forming units (CFUs) per 300 cells plated is given. Each value represents the average of four individual
mice, each measured in triplicate. (E, F) Gene expression analysis of C/EBP
Con and C/EBP
cKO preGM cells (C/EBP
Con: n¼4; C/EBP
cKO: n¼5).
Data show average mRNA expression normalized to Hprt1, each mouse assayed in triplicate. Error bars indicate standard deviations and
asterisks indicate statistical signiﬁcance (*Po0.05; **Po0.01; Student’s t-test).
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ﬂ/Y; Mx1-Cre
tg/þ:G A T A - 1
cKO mice),
as well as the corresponding control mice (Gata1
þ/Y;
Mx1-Cre
tg/þ:G A T A - 1
Con mice). Twelve days after starting
poly(I-C) treatment, we observed no effect on platelet or
leukocyte numbers (Figure 2A and B), but a speciﬁc loss of
peripheral red blood cells (Figure 2B). The lack of any
signiﬁcant effect of GATA-1 deﬁciency on platelets is consis-
tent with a previous study demonstrating a mild megakar-
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(Gutierrez et al, 2008). In accordance with that study, we
also observed accumulation in the bone marrow of early
erythroid progenitors, apparently blocked at the pro-erythro-
blast stage (Figure 2C). However, a signiﬁcant decrease in the
total number of erythroid progenitors (Figure 2D) suggested
Figure 2 Loss of GATA-1 prevents formation of committed erythroid progenitors. (A) Differential count of peripheral blood cells 12 days after
poly(I-C) treatment (GATA-1
Con: n¼10; GATA-1
cKO: n¼8). WBCs, total white blood cells; NEs, neutrophils; LYs, lymphocytes; MOs,
monocytes; PLT, platelets. (B) Red cell parameters measured as in (A). HCT, haematocrit; Hb, haemoglobin level; RBC, red blood cell
count. Error bars show standard deviations. Asterisks indicate statistical signiﬁcance (*Po0.05; **Po0.0001; ***Po0.00001). (C) Total bone
marrow cells from GATA-1
Con (left panel) and GATA-1
cKO (right panel) mice day 12 after poly(I-C) injection were stained for CD71 and Ter119 to
identify erythroid progenitor populations. Values shown are the size of gated populations as percentage of the total number of cells. I, pro-
erythroblasts; II, basophilic erythroblasts; III, polychromatophilic erythroblasts; IV, orthochromatophilic erythroblasts. (D) Bar graphs
represent percentage of the total number of cells in BM for each population gated as in (C). (E) Representative ﬂow cytometric analysis of
the experimental progenitor population from GATA-1
Con and GATA-1
cKO mice 12 days after poly(I-C) treatment. The schematic representation
(top) indicates the gating strategy used for separating the different myelo-erythroid progenitor sub-populations from GATA-1
Con (middle panels)
and GATA-1
cKO (bottom panels). The size of each population as percentage of the parental population is shown next to each gate. (F) Bar graphs
represent the average size of each myelo-erythroid progenitor population as percentage of the Lin/Sca-1/IL7Ra–c-Kitþ fraction in GATA-1
Con
(n¼6) and GATA-1
cKO (n¼6) poly(I-C)-treated mice. (G) Absolute number of myelo-erythroid progenitor from each of the populations
analysed in (F). Numbers represent cells retrieved from tibias and femurs of each mouse.
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metric phenotyping of the progenitor compartment showed a
complete loss of the earliest stages of committed erythroid
progenitors, preCFU-Es and CFU-Es (Figure 2E–G). This was
accompanied by a signiﬁcant increase in MkPs, whereas
preGM/GMP numbers were unaffected. The GM versus Mk/
E bifurcation, therefore, seems not to involve GATA-1,
whereas the divergence of the E and Mk lineages does.
However, the possibility existed that erythroid progenitors
formed, which were undetectable by surface marker expres-
sion. To resolve this, we sorted preMegEs from GATA-1
Con
and GATA-1
cKO mice, and tested their erythroid colony form-
ing ability. This showed that GATA-1-deﬁcient preMegEs were
unable to form erythroid colonies (Figure 3A). Potentially,
this could be caused by the inability of GATA-1-deﬁcient
preMegEs to respond to erythropoietin, the cytokine driving
the CFU-E assay, rather than their inability to form erythroid
cells. However, gene expression analysis of GATA-1
Con and
GATA-1
cKO preMegEs showed that Gata1 expression was lost
upon deletion, whereas Epor expression was normal. Gata2,
Klf1 and Zfpm1 were upregulated (Figure 3B), indicating that
the encoded factors, all of which are associated with ery-
throid differentiation, are insufﬁcient to mediate lineage
commitment in the absence of GATA-1. Analysis of gene
expression at the single cell level gave a similar result: the
proportion of Epor expressing cells was not altered, whereas
Klf1 and Gata2 expressing cells were increased (Figure 3C).
Overall, these results indicate that GATA-1 is required for
erythroid development at the level of lineage commitment,
whereas GATA-1 deﬁciency did not have any detectable effect
on divergence of the GM lineages from the Mk/E lineages.
FOG-1 is required for megakaryocyte and erythroid-
lineage commitment
GATA-1 is co-expressed with GATA-2 in most Mk/E progeni-
tors and mature cells, and redundancy between these factors
could explain why Gata1 deletion did not affect GM progeni-
tor formation. Both GATA-1 and GATA-2 use FOG-1 as a
co-factor during Mk/E differentiation (Chang et al, 2002).
We, therefore, conditionally inactivated the Zfpm1 gene as a
way to access the combined function of the two GATA factors,
since FOG-1 is not known to have GATA-independent activ-
ities. Initial experiments, using Zfpm1
ﬂ/ﬂ; Mx1-Cre
tg/þ
(FOG
cKO genotype) and Zfpm1
þ/þ; Mx1-Cre
tg/þ (FOG
Con
genotype) mice resulted in very rapid lethality of the
FOG
cKO mice upon poly(I-C) injection. Since FOG-1 is ex-
pressed in several non-haematopoietic tissues, we trans-
planted total bone marrow from FOG
cKO and FOG
Con mice
(CD45.2 allotype) into wild-type recipients (CD45.1/2
allotype). One month after transplantation the exclusive
reconstitution of the recipient haematopoietic system by the
donor cells was veriﬁed by analysis of the peripheral blood
(PB; Supplementary Figure S1), and recombination induced
by poly(I-C) injection. This led to lethality within 8 days of
the FOG
cKO mice, with no loss of viability of FOG
Con mice
(Figure 4A), accompanied by severe anaemia and thrombo-
cytopenia (Figure 4B–D). However, the transient effects of
interferon-b induced by poly(I-C) on the haematopoietic
stem/progenitor compartment precluded detailed analysis
of progenitor populations before the lethal effects of the
deletion occurred. To circumvent this problem, we
next included wild-type CD45.1 competitor cells in the
transplantation experiment in a 1:1 ratio with FOG
cKO and
FOG
Con cells. No lethality was observed after poly(I-C) treat-
ment, and mice could be analysed at steady state 3 months
Figure 3 Loss of erythroid colony forming potential by GATA-1-
deﬁcient preMegEs. (A) CFU-E forming capacity of GATA-1
Con and
GATA-1
cKO preMegEs. preMegE cells were sorted from GATA-1
Con
and GATA-1
cKO mice 12 days after poly(I-C) injection and assayed
for CFU-E activity (M3436). The values represent the average of
three individually sorted mice, each assayed in duplicate. (B) Gene
expression analysis of GATA-1
Con and GATA-1
cKO preMegEs obtained
as in (A) was performed using real-time PCR. Values represent the
average obtained from three individually sorted mice, each assayed
in triplicate. Error bars indicate standard deviations and asterisks
indicate statistical signiﬁcance (*Po0.05; **Po0.01; Student’s
t-test). (C) Single cell level gene expression in GATA-1
Con and
GATA-1
cKO preMegEs analysed by nested multiplex PCR. Values
represent the percentage of cells scored as positive for the indicated
transcripts. More than 85 single cells were assayed per genotype,
and those scoring positive for Kit mRNA were included in the
analysis (o3% were negative).
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S2A). Under these conditions, blood values were largely
normal, although a decrease in platelet numbers was
observed (Supplementary Figure S2B–G). In the donor-
derived CD45.1–CD45.2þ BM fraction, we observed that
FOG
cKO cells displayed a strong bias towards myeloid
Figure 4 Haematopoietic FOG-1 is essential for survival of adult mice. (A) Kaplan–Meier survival curve of wild-type mice transplanted with
FOG1
Con (n¼17) and FOG1
cKO bone marrow cells (n¼17) and injected with poly(I-C) (150mg/mouse) 4 weeks after transplantation. The
graph shows the fraction of live mice for each genotype. Statistical signiﬁcance between groups was calculated using the log-rank test.
(B) Differential count of peripheral blood cells 5 days after poly(I-C) treatment (FOG1
Con: n¼7; FOG1
cKO: n¼8). WBCs, total white blood cells;
NEs, neutrophils; LYs, lymphocytes; MOs, monocytes. (C) Platelet (PLT) count measured as in (B). (D) Red cell parameters measured as in (B).
HCT, haematocrit; Hb, haemoglobin level; RBC, red blood cell count. Error bars show standard deviations. Asterisks indicate statistical
signiﬁcance (*Po0.05; **Po0.0001; ***Po0.00001).
Figure 5 FOG-1-deﬁcient haematopoietic stem cells are unable to generate megakaryocyte-erythroid progenitors or colonies.
(A) Representative ﬂow cytometric analysis of the experimental progenitor population (CD45.1–CD45.2þLin/Sca-1/IL7Ra–c-Kitþ) from
FOG
Con (middle panels) and FOG
cKO (bottom panels). The schematic representation (top) indicates the gating strategy used for separating the
different myelo-erythroid progenitor sub-populations. The size of each population as percentage of the parental population is shown next to
each gate. (B) Bar graph showing the average size of each myelo-erythroid progenitor population as percentage of the CD45.1–CD45.2þLin/
Sca-1/IL7Ra–c-Kitþ fraction in FOG1
Con (n¼10) and FOG1
cKO (n¼10) competitively transplanted mice. Data were pooled from two
independent experiments. (C) Absolute number of myelo-erythroid progenitor from each of the populations analysed in (B). Numbers
represent cells retrieved from tibias and femurs of each mouse. (D) Lineage potential in vitro of CD45.1–CD45.2þLin–Sca-1þc-KitþFlt3–
stem/multipotent progenitor fraction sorted from FOG1
Con and FOG1
cKO competitively transplanted mice. Three hundred cells were plated in
semisolid medium under Mk (MegaCult-C), E (M3436) and GM conditions (M3534), respectively. The lineage potential of each cell population
is expressed as the percentage of the total number of colonies formed under all three conditions. Independently transplanted mice (FOG1
Con:
n¼6; FOG1
cKO: n¼6) were analysed for each genotype in two separate experiments, each performed in triplicate (GM, E) or in quadruplicate
(Mk). Error bars show standard deviations and asterisks indicate statistical signiﬁcance (*Po0.05; **Po0.01; ***Po0.001; Student’s t-test).
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preCFU-E/CFU-E and MkP populations were virtually absent
(Figure 5A), both when measured as proportion of the Lin–c-
Kitþ progenitor pool (Figure 5B) and as absolute cell number
(Figure 5C). No effect was observed on the CD45.1þCD45.2–
competitor cells (Supplementary Figure S3), indicating that the
effects of FOG-1 depletion on progenitor formation were cell
intrinsic. These results showed an inability of FOG-1-deﬁcient
haematopoietic stem cells (HSCs) to progress towards MkE
differentiation. To conﬁrm this, we performed colony forming
assays on the CD45.1–CD45.2þLSKFlt3– fraction: here, FOG
Con
cells showed CFU-GM, CFU-Mk and CFU-E activity as expected,
whereas elevated CFU-GM activity was found in FOG
cKO cells,
along with a complete loss of MkE potential (Figure 5D).
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and Mk/E colony forming cells provided strong evidence for a
differentiation block along these lineages, it could not be for-
mally excluded that the absence of phenotypic progenitors
was due to a change in their surface phenotype, and that FOG-
1 - d e ﬁ c i e n tH S C ss t i l lw e r ea b l et og e n e r a t ep l a t e l e t sa n d
erythrocytes. The CD45 allotype-speciﬁc antibodies cannot be
used to address this issue, since neither platelets nor erythrocytes
express CD45. In order to address this question, we therefore
took advantage of the Vwf-EGFP (Sanjuan-Pla et al, in prepara-
tion) and the miR-144/451-EGFP (Rasmussen and O’Carroll,
2011) reporter mouse lines, where platelets and erythrocytes,
Figure 6 FOG-1-deﬁcient haematopoiesis does not produce erythrocytes or platelets. (A) CD45.1/2 recipient mice were co-transplanted with
500000 Vwf-EGFP
tg/þ and 2000000 of either FOG
Con or FOG
cKO bone marrow cells. PB was analysed by ﬂow cytometry 4 weeks after
transplantation. Mice were then injected with poly(I-C). Eighteen days after the ﬁrst poly(I-C) injection (two injections, 2 day intervals) PB
analysis was performed. Platelets were identiﬁed by scatter and co-expression of CD41 and CD150, and the percentage of platelets expressing
EGFP determined. Representative plots are shown. (B) CD45.1/2 recipient mice were co-transplanted with 1000000 mir144/451
EGFP/þ and
2000000 of either FOG
Con or FOG
cKO bone marrow cells. PB was analysed by ﬂow cytometry 4 weeks after transplantation. Mice were then
injected with poly(I-C). In all, 31 and 45 days after the ﬁrst poly(I-C) injection (three injections, 2 day intervals), PB analysis was performed
(only 45 day time point is shown). Erythrocytes were identiﬁed by scatter and expression of Ter119, and the percentage of erythrocytes
expressing EGFP determined. Representative plots are shown. (C) Summary of data obtained in (A), showing the percentage of EGFPþ and
EGFP– platelets before and after poly(I-C) injection. FOG
Con: N¼7; FOG
cKO: N¼7. Error bars show standard deviations. Asterisks indicate
statistical signiﬁcance (***Po0.001; Student’s t-test). (D) Summary of data obtained in (B), showing the percentage of EGFPþ and EGFP–
erythrocytes before and after poly(I-C) injection. FOG
Con: N¼4; FOG
cKO: N¼5. Error bars show standard deviations. Asterisks indicate
statistical signiﬁcance (****Po0.0001; Student’s t-test).
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unrecombined FOG
Con/FOG
cKO and Vwf-EGFP mice, followed by
poly(I-C) injection, we observed that in the FOG
cKO chimeras
essentially all EGFP
  platelets were lost after 18 days
(Figure 6A, C). Similar experiments using the miR-144/451-
EGFP knockin showed that EGFP
  erythrocytes were lost, with
somewhat slower kinetics (Figure 6B, D). Since the output of
short-lived myeloid cells from FOG
cKO HSCs was maintained in
competitively repopulated recipients for several months after
poly(I-C) induction (Figure 5A), the loss of EGFP
  platelets and
erythrocytes indicates that production of these cell types is
indeed blocked in the absence of FOG-1.
Some residual commitment towards the Mk and E lineages
was suggested by the presence of FOG
cKO cells with the
surface phenotype of bipotent preMegEs. Cell sorting and
qPCR gene proﬁling of this population conﬁrmed the absence
of Zfpm1 expression; expression of Gata2 was increased,
whereas Gata1 mRNA levels were not signiﬁcantly altered.
Interestingly, myeloid genes (Sfpi1, Mpo) were upregulated in
FOG
cKO preMegEs (Figure 7A), as were both Cebpa and Cebpb
(Figure 7B). Gene proﬁling at the global level showed that the
gene expression pattern of FOG
cKO preMegEs was highly
signiﬁcantly depleted of mRNAs associated with the normal
preMegE phenotype, with an equally strong upregulation of
preGM-associated genes (as deﬁned by Pronk et al, 2007;
Figure 7C). Since preMegEs and preGMs deﬁne the ﬁrst
committed progenitors derived from the HSC compartment,
we used these gene sets to determine whether a lineage
commitment bias was introduced into HSCs upon FOG-1
depletion. We observed similar reprogramming in the
LSKFlt3
  HSC fraction (Figure 7D), with signiﬁcant depletion
of preMegE genes and upregulation of preGM genes. The
failure of FOG-1-deﬁcient progenitors to upregulate Mk/E
gene expression was, therefore, preceded by defective Mk/E
programming of HSCs. Using gene sets deﬁning mature
myeloid, erythroid and megakaryocytic cells, we previously
observed depletion of mature GM genes in HSCs homozygous
for a Cebpa point mutation that disables C/EBPa DNA bind-
ing (K313KK or KK allele) (Bereshchenko et al, 2009). Using
the early committed progenitor gene sets, we found that the
Cebpa KK mutation had the converse effect on HSC lineage
programming compared with FOG-1 conditional knockout,
leading to preGM gene depletion and preMegE gene enrich-
ment (Figure 7E). The inability of FOG-1-deﬁcient HSCs to
produce Mk/E colonies and give rise only to GM myeloid
colonies, combined with the myeloid reprogramming of
FOG
cKO preMegEs raised the question whether GM potential
was retained in this phenotypically Mk/E-committed cell
population. Sorted FOG
Con and FOG
cKO preMegEs exhibited
a different behaviour when plated under GM and E condi-
tions: the control preMegEs showed high E and Mk potential,
and very limited GM potential; FOG
cKO preMegEs readily
formed colonies only under GM conditions, but generated
no E or Mk colonies (Figure 7F). These results are consistent
with the loss of Mk/E-lineage commitment from preMegEs
being accompanied, and possibly caused by, their inability to
extinguish myeloid lineage-associated gene expression and
myeloid-lineage potential. To identify putative regulators of
FOG-1-dependent extinction of myeloid potential in
preMegEs, we mined the gene proﬁling data to identify
those genes that were (i) highly expressed in preMegEs, but
not in preGMs and CLPs and (ii) signiﬁcantly downregulated
in FOG
cKO preMegEs relative to FOG
Con preMegEs
(Supplementary Table S1). One of these genes was Trib2,
which is known to induce the degradation of C/EBPa and
C/EBPb (Figure 7G). We conﬁrmed the loss of Trib2 expres-
sion in FOG
cKO preMegEs by Q–PCR (Figure 7H). Finally, we
identiﬁed putative GATA binding sites in the Trib2 gene
(Figure 7I), one of which was found to bind both GATA-2
and FOG-1 in chromatin immune-precipitation (ChIP) experi-
ments performed on sorted preMegEs (Figure 7J).
Discussion
The results obtained in this manuscript identify FOG-1 and
GATA-1 as regulators of Mk/E-lineage speciﬁcation. Depleting
the haematopoietic system of C/EBPs blocked myelopoiesis
at the preGM to GMP transition. This was accompanied by
increased expression of the genes encoding Mk/E-lineage
regulators such as GATA-1, GATA-2 and FOG-1, as well
as increased Mk potential within the phenotypic preGM
compartment. Of these, FOG-1 was shown to be required
for the coordinated loss of GM priming and acquisition of
Mk/E priming associated with preMegE formation. This
identiﬁes FOG-1 as a transcription factor critical for the
generation of all Mk/E-committed cells, whereas GATA-1
was speciﬁcally required for the speciﬁcation of preCFU-E/
CFU-Es from preMegEs. Therefore, FOG-1 and GATA-1 act
sequentially during speciﬁcation of committed Mk/E progeni-
tors to separate these from GM progenitors, and subsequently
to segregate the Mk and E lineages.
GATA-1 is required for erythroid-lineage commitment
The essential role of GATA-1 in erythropoiesis has long been
established. Gata1 null embryos die around embryonic day
10.5 due to defective primitive erythropoiesis (Fujiwara et al,
1996). More recently, deletion of Gata1 during deﬁnitive
haematopoiesis revealed a block of erythroid progenitor
maturation at the pro-erythroblast stage (Gutierrez et al,
2008). However, our inability to prospectively identify com-
mitted unilineage E progenitors has so far precluded analysis
of the role of GATA-1 in lineage commitment processes. Using
the progenitor phenotyping scheme developed by Bryder and
colleagues (Pronk et al, 2007) we here show that acute Gata1
deletion leads to a complete block of preCFU-Es and CFU-Es,
the earliest erythroid-committed progenitors thus far identi-
ﬁed. Loss of GATA-1 did not affect the numbers of preMegEs,
preGMs or GMPs, but was accompanied by an increase of
MkPs, indicating that in the absence of GATA-1 the allocation
of progenitors at the Mk/E versus GM bifurcation is not
signiﬁcantly affected, whereas preMegEs showed only Mk-
lineage commitment. Interestingly, other transcription factors
involved in erythroid differentiation (Klf1, Gata2, Zfpm1,
Epor) were not downregulated in preMegEs, showing that
the impairment in E progenitor formation was not due to a
general loss of erythroid regulators, but to a speciﬁc require-
ment for GATA-1 at the Mk- versus E-lineage bifurcation.
Other regulatory mechanisms have been identiﬁed that
inﬂuence the relative Mk–E lineage output: miR-150 represses
c-Myb expression, and miR-150 overexpression (Lu et al,
2008) or hypomorphic Myb alleles (Emambokus et al,
2003; Mukai et al, 2006) both led to overproduction of
megakaryocytes, whereas miR-150 knockdown or c-Myb
overexpression had the opposite effect. Activation of Notch
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tion: exposure to Notch ligands or transduction with the
Notch1 intracellular domain increased megakaryocytic out-
put in sorted murine stem and progenitor cell populations
in vitro, and Notch inhibition reduced the number of mega-
karyocyte-erythroid progenitors (MEPs) and megakaryocytes
in vivo (Mercher et al, 2008). These results are consistent
with a role for these mechanisms in Mk versus E unilineage
progenitor speciﬁcation. It will now be important to
determine whether this is the case, and to which extent
FOG-1 and GATA-1 in lineage commitment
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during this process.
FOG-1 is required for formation of all committed Mk
and E progenitors
In the absence of FOG-1, we observed a complete loss of
progenitors committed to the Mk and E lineages: MkPs,
preCFU-Es, and CFU-Es were all absent, whereas myeloid-
committed preGM and GMP progenitors were correspond-
ingly increased. Loss of FOG-1 did not signiﬁcantly alter the
total number of myelo-erythroid progenitors, but simply
altered their distribution. The current paradigm for separa-
tion of the GM and Mk–E lineages is thought to be
PU.1–GATA-1 antagonism. PU.1 was observed to instruct
myeloid differentiation in transformed avian multipotent
progenitors while downregulating GATA-1 (Nerlov and Graf,
1998). Conversely, GATA-1 suppressed the myeloid pheno-
type of, and conferred MkE potential on, committed myeloid
cells (Kulessa et al, 1995). In addition, PU.1 and GATA-1 (and
GATA-2) showed functional antagonism through direct pro-
tein–protein interaction (Rekhtman et al, 1999; Zhang et al,
1999; Nerlov et al, 2000) as well as positive autoregulation
through binding to their own promoters (Tsai et al, 1991;
Okuno et al, 2005). Mathematical modelling has shown that a
system with these properties is capable of maintaining an
uncommitted metastable state that bifurcates into stable
committed states when either of the two factors prevail
(Huang et al, 2007).
The present results indicate that also FOG-1 plays a key
role in this lineage bifurcation. FOG-1 null embryos die
around embryonic day 11.5 and show arrested development
of primitive erythrocytes and lack of megakaryocytes (Tsang
et al, 1998). Furthermore, decreased erythropoiesis and
thrombopoiesis, and increased myelopoiesis have been re-
ported in morpholino-based FOG-1 knockdown in zebraﬁsh
(Amigo et al, 2009). It has, however, not been clear to which
extent these abnormalities reﬂect lack of lineage commitment
or subsequent differentiation defects. In addition, FOG-1 has
been shown to repress eosinophil-speciﬁc gene expression
through GATA-1/2 bound to eosinophil-speciﬁc promoters
(Yamaguchi et al, 1999), and to block eosinophil speciﬁcation
(Querfurth et al, 2000). A similar role for FOG-1 in suppres-
sion of mast cell gene expression and differentiation has been
demonstrated (Cantor et al, 2008). The repressor function of
FOG-1 has been located to an N-terminal NuRD-recruitment
domain (Hong et al, 2005). Recently, knock-in mutagenesis
disabling NuRD interaction of FOG-1 resulted in ectopic
expression of myeloid and mast cell genes in heterologous
cell types (Gao et al, 2010; Gregory et al, 2010; Miccio et al,
2010). However, no major defects in lineage speciﬁcation
were observed. The present results show that complete loss
of FOG-1 results in loss of Mk/E-lineage progenitor commit-
ment. Competitive transplantation experiments using bone
marrow genetically modiﬁed to allow tracking of platelets
and erythrocytes showed that the lack of FOG
cKO MkPs,
preCFU-Es and CFU-Es was accompanied by a loss of mature
cells of these lineages, arguing against the absence of these
progenitors being due to an altered surface phenotype. The
absence of Mk/E-lineage progenitors was also accompanied
by loss of Mk/E-lineage programming and ectopic myeloid
gene expression in the remaining phenotypic preMegEs.
FOG-1-deﬁcient preMegEs showed exclusively myeloid
potential in vitro. This demonstrates a novel FOG-1 function
in lineage speciﬁcation, which is at least partially indepen-
dent of NuRD complex interaction. Ectopic myeloid
differentiation was observed from Mk/E progenitors in
FOG-1–NuRD interaction mutant mice (Gregory et al, 2010),
indicating that suppression of myeloid potential by FOG-1 at
least partially requires NuRD recruitment, whereas the
acquisition of Mk/E potential can proceed in its absence.
Transcriptional lineage priming of haematopoietic stem
and progenitor cells has been shown to deﬁne their lineage
potential (Hu et al, 1997; Mansson et al, 2007). We here
observe that the inability of FOG-1-deﬁcient HSCs to generate
committed Mk/E progenitors is associated with their loss of
preMegE-speciﬁc gene expression and upregulation of
preGM-associated genes. The altered allocation of early
myelo-erythroid progenitors from FOG
cKO HSCs is, therefore,
preceded by a corresponding imbalance in the gene expres-
sion programs deﬁning the earliest progenitors in the two
differentiation pathways, supporting the importance of HSC
priming for subsequent lineage commitment. We have
previously shown that Cebpa loss-of-function mutations
decrease myeloid priming of HSCs while simultaneously
impairing myeloid-lineage commitment (Bereshchenko
et al, 2009). Using the preGM and preMegE gene sets, we
here extend this analysis by showing that disruption of C/EBP
function in HSCs perturbs early Mk/E and GM progenitor
gene expression in a manner converse to that of FOG-1
depletion, consistent with the negative cross-regulation
between FOG-1 and C/EBPs translating into opposing roles
in global lineage programming and lineage commitment.
Figure 7 Loss of FOG-1 prevents extinction of the GM program in preMegE cells. (A, B) Quantitative RT–PCR on sorted bone marrow preMegE
isolated from FOG1
Con and FOG1
cKO competitive-transplanted mice. Data show average mRNA expression normalized to Hprt1 from three
independently transplanted mice, each mouse assayed in triplicate. (C) Gene set enrichment analysis comparing FOG1
cKO and FOG1
Con
preMegEs and (D) LSKFlt3
  cells. Panels show enrichment of preMegE (top)- and preGM (bottom)-speciﬁc gene sets in the FOG1
cKO genotype
relative to FOG1
Con. The normalized enrichment score (NES), nominal P-value and false discovery rate (FDR) are indicated on each plot.
(E) Gene set enrichment analysis comparing Cebpa
KK and wild-type (WT) control LSK cells. Panels show enrichment of preMegE (top)- and
preGM (bottom)-speciﬁc gene sets in the Cebpa
KK genotype relative to wild type. The NES, nominal P-value and FDR are indicated on each plot.
(F) Lineage potential of FOG1
Con and FOG1
cKO PreMegEs, assayed as in Figure 1D. Error bars show standard deviations. Asterisks indicate
statistical signiﬁcance (*Po0.05; **Po0.01; ***Po0.001; Student’s t-test). (G) Expression of Trib2 in progenitor subsets based on Affymetrix
array analysis of CLP (n¼3), preGM (n¼3) and preMegE populations (n¼5). Expression values are normalized to Hprt expression. Error bars
indicate standard deviations. Asterisks indicate statistical signiﬁcance (***Po0.001; Student’s t-test). (H) Expression of Trib2 in control and
FOG-1-deﬁcient preMegEs based on real-time Q–PCR (Con: N¼3; cKO; N¼3) and Affymetrix analysis (Con: N¼3; cKO; N¼3). Asterisks
indicate statistical signiﬁcance (*Po0.05; ***Po0.001; Student’s t-test). (I) Trib2 promoter region, showing the position of the amplicons
surrounding putative GATA/FOG binding sites, identiﬁed by sequence analysis. Arrow indicates the transcriptional start site; open box 50 non-
coding part of exon 1; closed box coding sequence. (J) ChIP was performed on sorted preMegEs (50000cells/IP), using anti-GATA-2, anti-FOG-
1 and control IgG antibodies, followed by PCR ampliﬁcation of Trib2 and control Csn2 amplicons. Values are expressed as enrichment
(antibody/IgG ratio) relative to the enrichment observed for the Csn2 amplicon. Each value is the average of triplicate determinations.
FOG-1 and GATA-1 in lineage commitment
E Mancini et al
&2012 European Molecular Biology Organization The EMBO Journal VOL 31 | NO 2 | 2012 361Suppression of myeloid progenitor speciﬁcation by FOG-1
While loss of GATA-1 by itself did not disturb the allocation of
Mk/E versus GM progenitors in vivo this could be explained
by functional redundancy with GATA-2, which is also able to
antagonize PU.1 activity. A larger issue is how FOG-1 inter-
acts with the PU.1–GATA-1/2 antagonism. This potentially
involves multiple mechanisms. First, since interaction of
GATA-1 with PU.1 and FOG-1 has been observed to be
mutually exclusive (Sugiyama et al, 2008), FOG-1 may act
as a co-factor for GATA-1 on the GATA-1 promoter and impair
the ability of PU.1 to repress Gata1 expression. Second, we
observe cross-regulation of Zfpm1 and Cebpa/Cebpb during
the GM versus Mk/E segregation: loss of FOG-1 led to
upregulation of Cebpa and Cebpb in preMegEs, whereas
C/EBP-depleted preGM cells showed increased Zfpm1 expres-
sion. In both cases, this correlated with altered lineage
potential of the blocked progenitor population (summarized
in Figure 8).
Mining of microarray data identiﬁed the C/EBP antagonist
Trib2 as a potential effector of FOG-1-mediated extinction of
myeloid potential. Trib2 is selectively expressed in preMegEs,
but not in CLPs and preGMs; its promoter region binds
GATA-2/FOG-1 in sorted preMegEs; and its expression is
strongly reduced in the absence of FOG-1. Trib2 is able to
selectively degrade the long isoforms of C/EBPa and C/EBPb
(Keeshan et al, 2006; Naiki et al, 2007), which are the
transcriptionally active isoforms (Nerlov, 2007). While it
has been shown that viral transduction of Trib2 into the
haematopoietic system is leukaemogenic (Keeshan et al,
2006) in the same manner as loss of the long C/EBPa p42
isoform (Kirstetter et al, 2008); however, it has so far not been
addressed whether Trib2 expression alters myeloid-lineage
allocation. Now, it will be of interest to directly examine the
role of Trib2 in Mk/E-lineage formation. In addition, C/EBPs
are known to positively regulate Sfpi1 expression (Kummalue
and Friedman, 2003; Yeamans et al, 2007); this provides a
potential interface between PU.1–GATA-1 and FOG-1–C/EBP
cross-regulation. Finally, C/EBPs have been described to
functionally antagonize GATA factors (Tong et al, 2005)
through protein–protein interaction, suggesting a proteomic
contribution of C/EBPs in addition to direct gene regulation.
The simple model of PU.1–GATA-1 antagonism controlling
the segregation of the Mk/E and GM lineages, therefore,
likely needs to be replaced by a more complex model
where PU.1 and C/EBPs collectively antagonize GATA-1/2
and FOG-1 through several independent mechanisms.
Materials and methods
Mouse lines
Zfmp1 (Katz et al, 2003), Gata1 (Lindeboom et al, 2003) Cebpa (Lee
et al, 1997) and Cebpb (Lopez et al, 2009) conditional alleles and
Figure 8 Lineage perturbations in FOG-1- and C/EBP-deﬁcient haematopoiesis. (A) The myelo-erythroid lineage bifurcation in normal
haematopoiesis. (B) In FOG-1-deﬁcient haematopoiesis, phenotypic preMegEs upregulate Cebpa and Cebpb, assume preGM-like gene
expression and give rise to myeloid cells, but no committed Mk or E progenitors or colonies. (C) Conversely, C/EBP-deﬁcient preGM cells
are blocked in the progression to the GMP stage, upregulate Zfpm1 (encoding FOG-1) and Mk-speciﬁc genes, and show ectopic Mk potential.
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generated. miR144/451
EGFP mice have been described (Rasmussen
and O’Carroll, 2011). Details of the Vwf-EGFP line will be published
elsewhere (A Sanjuan-Pla, C Nerlov and SE Jacobsen, in prepara-
tion). Poly(I-C) induced recombination, lethal irradiation and bone
marrow transplantation were carried out as described (Kirstetter
et al, 2008). Animal experiments were carried out with the approval
of the EMBL Monterotondo Ethical Committee and the University of
Edinburgh Ethical Committee.
Flow cytometry and colony assays
Measurement and analysis of haematological parameters, ﬂow
cytometric analysis and sorting of progenitors were performed as
described (Kirstetter et al, 2006; Bereshchenko et al, 2009). A list of
antibodies and dilutions used is provided in Supplementary
Experimental Procedures. Media for colony forming assays for
GM (M3436), E (M3534) and Mk lineages (MegaCult-C) were from
Stem Cell Technologies (Vancouver, Canada) and used according to
the manufacturer’s instructions. Colonies generated in methylcellu-
lose were scored as blasts, GM, BFU-E, and Mk colonies by
morphologic criteria, and for megakaryocytic progenitors by
acetylcholinesterase staining. Cells were plated in triplicate, or
quadruplicate, and colonies were scored after 5 days (GM colonies)
and 10 days (BFU-E and Mk colonies).
Gene expression analysis
RNA puriﬁcation and Q–PCR analysis of sorted cells were as
previously described (Ruffell et al, 2009), except that Hprt
expression was used for normalization. Statistical signiﬁcance
was determined using Student’s t-test. A list of TaqMan probe sets
(Applied Biosystems, Foster City, CA, USA) used is provided in
Supplementary Experimental Procedures.
Microarray analysis was performed at the Copenhagen Uni-
versity Hospital Microarray Unit. Total RNA from 5000 sorted cells
was ampliﬁed using the WT-Ovation Exon Module, biotin labelled
with FL-Ovation Biotin Module V2 kit (Nugen, San Carlos, CA,
USA) and hybridized to Mouse Gene 1.0 ST GeneChip arrays
(Affymetrix, Santa Clara, CA, USA) according to the manufacturers’
instructions. Normalization and GSEA analysis (Subramanian et al,
2005) were performed as described (Bereshchenko et al, 2009)
using CLP, preGM and preMegE gene sets (Pronk et al, 2007). Cebpa
mutant HSC microarray data have previously been published
(Bereshchenko et al, 2009). Microarray data have been deposited
in the ArrayExpress database (http://www.ebi.ac.uk/microarray-
as/ae/) with the accession number E-MTAB-342.
Multiplex single-cell RT–PCR analysis was performed as pre-
viously described (Hu et al, 1997; Adolfsson et al, 2005; Mansson
et al, 2007). The genes investigated have previously been validated
for their lineage speciﬁcity in early committed progenitors of
different lineages (Mansson et al, 2007). The primers used for
nested multiplex single-cell PCR are listed in Supplementary
Experimental Procedures.
For analysis of Trib2 expression, 200 preMegE cells were sorted
into 10ml CellsDirect (Invitrogen) mix containing 1  CellsDirect
Reaction Mix, 1ml RT-Taq mix, and 200nM primers against genes
including Trib2 and Hprt. Reverse transcription was performed at
501C for 15min, followed by a 2-min incubation at 951C and pre-
ampliﬁcation for 22 cycles of 951C for 15s and 601C for 4min. Pre-
ampliﬁed samples were diluted to 50ml with TE, and 2.5ml of each
sample was assayed in triplicate against UPL assays (Roche) for the
target genes, also loaded in triplicate, on a Fluidigm 48.48 Dynamic
Array. PCRs were performed on a BioMark HD instrument using the
following conditions: 501C for 2min; 951C for 10min; 40 cycles of
951C for 15s, 581C for 5s, 601C for 1min. Thresholds were set
manually for each assay prior to calling CTs. Reactions with no
ampliﬁcation were set to an arbitrary CT of 45, and relative
expression levels were calculated by the DDCt method. UPL
(Roche)-based Q–PCR primers were Trib2:5 0-TGGAGGGAGACCACG
TTTT-30 and 50-AGCAGCTGATCTCAAACACCT-30, UPL probe 17;
Hprt:5 0-TCCTCCTCAGACCGCTTTT-30 and 50-CCTGGTTCATCATCGC
TAATC-30, UPL probe 95. Microarray-based expression was calcu-
lated on RMA-processed data (FOG
cKO versus FOG
Con), and using
GCRMA-normalized published data (Pronk et al, 2007) (comparison
of CLP, preGM and preMegE populations).
Chromatin IP
In all, 50000 PreMegEs were sorted into DPBS (Gibco) supplemen-
ted with 5% FBS, and crosslinked in DMEM/1% formaldehyde for
10min at room temperature. The reaction was stopped by adding
glycine to a ﬁnal concentration of 0.125M. Cells were washed twice
in ice-cold HBSS, and lysed in 200ml of lysis buffer (50mM
Tris–HCl, pH 8.0, 10mM EDTA, 1% SDS) on ice for 20min. Chromatin
was fragmented using Bioruptor (Diagenode) to obtain genomic
fragments ranging from 200 to 500bp. Samples were diluted with one
volume of RIPA buffer containing protease inhibitor cocktail. ChIP
assays were performed using 0.25mg anti-GATA-2 (H-116) antibody,
0.5mg anti-FOG-1 (M-20) antibody or an equal amount of control IgG
(Santa Cruz). Following overnight incubation at 41C, protein/DNA
complexes were captured with 20mlp r o t e i nGD y n a b e a d s( I n v i t r o -
gen). After 2h at 41C, beads were washed 2  with RIPA plus PIC
buffer, 4  with RIPA containing 500mM NaCl plus PIC, 1  LiCl
buffer without protease inhibitor, 2  TE buffer (10mM Tris–HCl, pH
8.0, 10mM EDTA) and ﬁnally resuspended in 100ml cold TE buffer
containing RNAse A (50mg/ml) and incubated at 371Cf o r3 0 m i n .
Protease inhibitor cocktail (Roche) was added to all buffers. DNAwas
eluted twice with 200ml elution buffer (20mM Tris–HCl, pH 7.5, 5mM
EDTA, 50mM NaCl) containing 1% SDS and Proteinase K. Crosslinks
were reversed at 681C for 2h with shaking at 1300r .p.m. Genomic
DNA was recovered using phenol chloroform extraction and ethanol
precipitation. Pellets were washed in 70% ethanol, brieﬂy air dried,
and resuspended in TE buffer (pH 8.0). The DNA was pre-ampliﬁed
with speciﬁc primer using Taqman pre-amp master mix (Applied
Biosystems). Putative GATA sitesw e r el o c a t e du s i n gT R A N S F A C
v2010.4 (Matys et al, 2006). Enrichment of the ChIP sample over input
was conﬁrmed by UPL-based Q–PCR. Enrichment was determined as
the ratio between immune and non-immune IgG, and normalized to
the values obtained for the Csn2 negative control. The following
amplicons were used: Trib2-1: 50-TTGTGACTAGAAATTGGGTACATGA-
30 and 50-CAGCACATGTAGGGAAGCTG-30,U P Lp r o b e# 3 2 ;Trib2-2:
50-CGAAGAGCTGTCGTCTATAAGGT-30 and 50-AACCTTGGCTCTCC-
GAGC-30, UPL probe#20; Csn2:5 0-CGTCTTACTGTGCCTCTCCA-30 and
50-CATGGCCACAATTCTTGGTT-30, UPL probe #82.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
Acknowledgements
We thank Dr Stuart Orkin (Harvard University, Cambridge, MA,
USA), Dr Sjaak Philipsen (Erasmus University, Rotterdam, The
Netherlands) and Dr Ying-Hue Lee (Academia Sinica, Nankang,
Taipei, Taiwan) for generously sharing mouse lines. This work
was funded by the European Commission (EuroCSC STREP), the
Associazione Italiana per la Ricerca sul Cancro (AIRC), the Swedish
Research Council (HematoLinne), as well as by a Strategic Grant
and Programme Grant to CN from the Medical Research Council.
Author contributions: EM, SEJ and CN planned the experiments.
AZ, AG, SM, EM, LL, AS-P and SL performed the experiments.
SM carried out bioinformatics. DB assisted with ﬂow cytometry. KR
and DO provided mouse line. EM, SEJ and CN wrote the paper.
Conﬂict of interest
The authors declare that they have no conﬂict of interest.
References
Adolfsson J, Mansson R, Buza-Vidas N, Hultquist A, Liuba K,
Jensen CT, Bryder D, Yang L, Borge OJ, Thoren LA, Anderson
K, Sitnicka E, Sasaki Y, Sigvardsson M, Jacobsen SE (2005)
Identiﬁcation of Flt3+ lympho-myeloid stem cells lacking
erythro-megakaryocytic potential a revised road map for adult
blood lineage commitment. Cell 121: 295–306
FOG-1 and GATA-1 in lineage commitment
E Mancini et al
&2012 European Molecular Biology Organization The EMBO Journal VOL 31 | NO 2 | 2012 363Akashi K, Traver D, Miyamoto T, Weissman IL (2000) A clonogenic
common myeloid progenitor that gives rise to all myeloid
lineages. Nature 404: 193–197
Amigo JD, Ackermann GE, Cope JJ, Yu M, Cooney JD, Ma D, Langer
NB, Shaﬁzadeh E, Shaw GC, Horsely W, Trede NS, Davidson AJ,
Barut BA, Zhou Y, Wojiski SA, Traver D, Moran TB, Kourkoulis G,
Hsu K, Kanki JP et al (2009) The role and regulation of friend of
GATA-1 (FOG-1) during blood development in the zebraﬁsh.
Blood 114: 4654–4663
Athanasiou M, Clausen PA, Mavrothalassitis GJ, Zhang XK,
Watson DK, Blair DG (1996) Increased expression of the ETS-
related transcription factor FLI-1/ERGB correlates with and can
induce the megakaryocytic phenotype. Cell growth Differ 7:
1525–1534
Athanasiou M, Mavrothalassitis G, Sun-Hoffman L, Blair DG (2000)
FLI-1 is a suppressor of erythroid differentiation in human
hematopoietic cells. Leukemia 14: 439–445
Bereshchenko O, Mancini E, Moore S, Bilbao D, Mansson R, Luc S,
Grover A, Jacobsen SE, Bryder D, Nerlov C (2009) Hematopoietic
stem cell expansion precedes the generation of committed
myeloid leukemia-initiating cells in C/EBPalpha mutant AML.
Cancer Cell 16: 390–400
Bouilloux F, Juban G, Cohet N, Buet D, Guyot B, Vainchenker W,
Louache F, Morle F (2008) EKLF restricts megakaryocytic differ-
entiation at the beneﬁt of erythrocytic differentiation. Blood 112:
576–584
Burda P, Laslo P, Stopka T (2010) The role of PU.1 and GATA-1
transcription factors during normal and leukemogenic hemato-
poiesis. Leukemia 24: 1249–1257
Cantor AB, Iwasaki H, Arinobu Y, Moran TB, Shigematsu H,
Sullivan MR, Akashi K, Orkin SH (2008) Antagonism of FOG-1
and GATA factors in fate choice for the mast cell lineage. J Exp
Med 205: 611–624
Chang AN, Cantor AB, Fujiwara Y, Lodish MB, Droho S, Crispino
JD, Orkin SH (2002) GATA-factor dependence of the multitype
zinc-ﬁnger protein FOG-1 for its essential role in megakaryopoi-
esis. Proc Natl Acad Sci USA 99: 9237–9242
Dakic A, Metcalf D, Di Rago L, Mifsud S, Wu L, Nutt SL (2005) PU.1
regulates the commitment of adult hematopoietic progenitors and
restricts granulopoiesis. J Exp Med 201: 1487–1502
Emambokus N, Vegiopoulos A, Harman B, Jenkinson E, Anderson
G, Frampton J (2003) Progression through key stages of haemo-
poiesis is dependent on distinct threshold levels of c-Myb. EMBO
J 22: 4478–4488
Frontelo P, Manwani D, Galdass M, Karsunky H, Lohmann F,
Gallagher PG, Bieker JJ (2007) Novel role for EKLF in megakar-
yocyte lineage commitment. Blood 110: 3871–3880
Fujiwara Y, Browne CP, Cunniff K, Goff SC, Orkin SH (1996)
Arrested development of embryonic red cell precursors in
mouse embryos lacking transcription factor GATA-1. Proc Natl
Acad Sci USA 93: 12355–12358
Gao Z, Huang Z, Olivey HE, Gurbuxani S, Crispino JD, Svensson EC
(2010) FOG-1-mediated recruitment of NuRD is required for
cell lineage re-enforcement during haematopoiesis. EMBO J 29:
457–468
Gregory GD, Miccio A, Bersenev A, Wang Y, Hong W, Zhang Z,
Poncz M, Tong W, Blobel GA (2010) FOG1 requires NuRD to
promote hematopoiesis and maintain lineage ﬁdelity within the
megakaryocytic-erythroid compartment. Blood 115: 2156–2166
Gutierrez L, Tsukamoto S, Suzuki M, Yamamoto-Mukai H,
Yamamoto M, Philipsen S, Ohneda K (2008) Ablation of Gata1
in adult mice results in aplastic crisis, revealing its essential role
in steady-state and stress erythropoiesis. Blood 111: 4375–4385
Hart A, Melet F, Grossfeld P, Chien K, Jones C, Tunnacliffe A, Favier
R, Bernstein A (2000) Fli-1 is required for murine vascular and
megakaryocytic development and is hemizygously deleted in
patients with thrombocytopenia. Immunity 13: 167–177
Hirai H, Zhang P, Dayaram T, Hetherington CJ, Mizuno S, Imanishi
J, Akashi K, Tenen DG (2006) C/EBPbeta is required for ‘emer-
gency’ granulopoiesis. Nat Immunol 7: 732–739
Hong W, Nakazawa M, Chen YY, Kori R, Vakoc CR, Rakowski C,
Blobel GA (2005) FOG-1 recruits the NuRD repressor complex
to mediate transcriptional repression by GATA-1. EMBO J 24:
2367–2378
Hu M, Krause D, Greaves M, Sharkis S, Dexter M, Heyworth C,
Enver T (1997) Multilineage gene expression precedes commit-
ment in the hemopoietic system. Genes Dev 11: 774–785
Huang S, Guo YP, May G, Enver T (2007) Bifurcation dynamics in
lineage-commitment in bipotent progenitor cells. Dev Biol 305:
695–713
Iwasaki H, Somoza C, Shigematsu H, Duprez EA, Iwasaki-Arai J,
Mizuno S, Arinobu Y, Geary K, Zhang P, Dayaram T, Fenyus ML,
Elf S, Chan S, Kastner P, Huettner CS, Murray R, Tenen DG,
Akashi K (2005) Distinctive and indispensable roles of PU.1 in
maintenance of hematopoietic stem cells and their differentiation.
Blood 106: 1590–1600
Katz SG, Williams A, Yang J, Fujiwara Y, Tsang AP, Epstein JA,
Orkin SH (2003) Endothelial lineage-mediated loss of the GATA
cofactor Friend of GATA 1 impairs cardiac development. Proc Natl
Acad Sci USA 100: 14030–14035
Keeshan K, He Y, Wouters BJ, Shestova O, Xu L, Sai H, Rodriguez
CG, Maillard I, Tobias JW, Valk P, Carroll M, Aster JC, Delwel R,
Pear WS (2006) Tribbles homolog 2 inactivates C/EBPalpha and
causes acute myelogenous leukemia. Cancer Cell 10: 401–411
Kirstetter P, Anderson K, Porse BT, Jacobsen SE, Nerlov C (2006)
Activation of the canonical Wnt pathway leads to loss of hema-
topoietic stem cell repopulation and multilineage differentiation
block. Nat Immunol 7: 1048–1056
Kirstetter P, Schuster MB, Bereshchenko O, Moore S, Dvinge H,
Kurz E, Theilgaard-Monch K, Mansson R, Pedersen TA, Pabst T,
Schrock E, Porse BT, Jacobsen SE, Bertone P, Tenen DG, Nerlov C
(2008) Modeling of C/EBPalpha mutant acute myeloid leukemia
reveals a common expression signature of committed myeloid
leukemia-initiating cells. Cancer Cell 13: 299–310
Kuhn R, Schwenk F, Aguet M, Rajewsky K (1995) Inducible gene
targeting in mice. Science 269: 1427–1429
Kulessa H, Frampton J, Graf T (1995) GATA-1 reprograms avian
myelomonocytic cell lines into eosinophils, thromboblasts, and
erythroblasts. Genes Dev 9: 1250–1262
Kummalue T, Friedman AD (2003) Cross-talk between regulators of
myeloid development: C/EBPalpha binds and activates the
promoter of the PU.1 gene. J Leukoc Biol 74: 464–470
Lee YH, Sauer B, Johnson PF, Gonzalez FJ (1997) Disruption
of the c/ebp alpha gene in adult mouse liver. Mol Cell Biol 17:
6014–6022
Lindeboom F, Gillemans N, Karis A, Jaegle M, Meijer D, Grosveld F,
Philipsen S (2003) A tissue-speciﬁc knockout reveals that Gata1 is
not essential for Sertoli cell function in the mouse. Nucleic Acids
Res 31: 5405–5412
Lopez RG, Garcia-Silva S, Moore SJ, Bereshchenko O, Martinez-
Cruz AB, Ermakova O, Kurz E, Paramio JM, Nerlov C (2009)
C/EBPalpha and beta couple interfollicular keratinocyte prolifera-
tion arrest to commitment and terminal differentiation. Nat Cell
Biol 11: 1181–1190
Lu J, Guo S, Ebert BL, Zhang H, Peng X, Bosco J, Pretz J, Schlanger
R, Wang JY, Mak RH, Dombkowski DM, Preffer FI, Scadden DT,
Golub TR (2008) MicroRNA-mediated control of cell fate in
megakaryocyte-erythrocyte progenitors. Dev Cell 14: 843–853
Mansson R, Hultquist A, Luc S, Yang L, Anderson K, Kharazi S,
Al-Hashmi S, Liuba K, Thoren L, Adolfsson J, Buza-Vidas N,
Qian H, Soneji S, Enver T, Sigvardsson M, Jacobsen SE (2007)
Molecular evidence for hierarchical transcriptional lineage prim-
ing in fetal and adult stem cells and multipotent progenitors.
Immunity 26: 407–419
Matys V, Kel-Margoulis OV, Fricke E, Liebich I, Land S, Barre-Dirrie
A, Reuter I, Chekmenev D, Krull M, Hornischer K, Voss N,
Stegmaier P, Lewicki-Potapov B, Saxel H, Kel AE, Wingender E
(2006) TRANSFAC and its module TRANSCompel: transcriptional
gene regulation in eukaryotes. Nucleic Acids Res 34: D108–D110
Mercher T, Cornejo MG, Sears C, Kindler T, Moore SA, Maillard I,
Pear WS, Aster JC, Gilliland DG (2008) Notch signaling speciﬁes
megakaryocyte development from hematopoietic stem cells. Cell
Stem Cell 3: 314–326
Miccio A, Wang Y, Hong W, Gregory GD, Wang H, Yu X, Choi JK,
Shelat S, Tong W, Poncz M, Blobel GA (2010) NuRD mediates
activating and repressive functions of GATA-1 and FOG-1 during
blood development. EMBO J 29: 442–456
Mukai HY, Motohashi H, Ohneda O, Suzuki N, Nagano M,
Yamamoto M (2006) Transgene insertion in proximity to the c-
myb gene disrupts erythroid-megakaryocytic lineage bifurcation.
Mol Cell Biol 26: 7953–7965
Naiki T, Saijou E, Miyaoka Y, Sekine K, Miyajima A (2007) TRB2, a
mouse Tribbles ortholog, suppresses adipocyte differentiation by
inhibiting AKT and C/EBPbeta. J Biol Chem 282: 24075–24082
FOG-1 and GATA-1 in lineage commitment
E Mancini et al
The EMBO Journal VOL 31 | NO 2 | 2012 &2012 European Molecular Biology Organization 364Nerlov C (2007) The C/EBP family of transcription factors: a
paradigm for interaction between gene expression and prolifera-
tion control. Trends Cell Biol 17: 318–324
Nerlov C, Graf T (1998) PU.1 induces myeloid lineage
commitment in multipotent hematopoietic progenitors. Genes
Dev 12: 2403–2412
Nerlov C, Querfurth E, Kulessa H, Graf T (2000) GATA-1 interacts
with the myeloid PU.1 transcription factor and represses
PU.1-dependent transcription. Blood 95: 2543–2551
Nuez B, Michalovich D, Bygrave A, Ploemacher R, Grosveld F
(1995) Defective haematopoiesis in fetal liver resulting from
inactivation of the EKLF gene. Nature 375: 316–318
Okuno Y, Huang G, Rosenbauer F, Evans EK, Radomska HS, Iwasaki
H, Akashi K, Moreau-Gachelin F, Li Y, Zhang P, Gottgens B, Tenen
DG (2005) Potential autoregulation of transcription factor PU.1 by
an upstream regulatory element. Mol Cell Biol 25: 2832–2845
Perkins AC, Sharpe AH, Orkin SH (1995) Lethal beta-thalassaemia
in mice lacking the erythroid CACCC-transcription factor EKLF.
Nature 375: 318–322
Porse BT, Bryder D, Theilgaard-Monch K, Hasemann MS, Anderson
K, Damgaard I, Jacobsen SE, Nerlov C (2005) Loss of C/EBPalpha
cell cycle control increases myeloid progenitor proliferation and
transforms the neutrophil granulocyte lineage. J Exp Med 202:
85–96
Pronk CJ, Rossi DJ, Mansson R, Attema JL, Norddahl GL, Chan CK,
Sigvardsson M, Weissman IL, Bryder D (2007) Elucidation of the
phenotypic, functional, and molecular topography of a myeloer-
ythroid progenitor cell hierarchy. Cell Stem Cell 1: 428–442
Querfurth E, Schuster M, Kulessa H, Crispino JD, Doderlein G,
Orkin SH, Graf T, Nerlov C (2000) Antagonism between C/
EBPbeta and FOG in eosinophil lineage commitment of multi-
potent hematopoietic progenitors. Genes Dev 14: 2515–2525
Rasmussen KD, O’Carroll D (2011) The miR-144/451eGFP allele, a
novel tool for resolving the erythroid potential of hematopoietic
precursors. Blood 118: 2988–2992
Rekhtman N, Radparvar F, Evans T, Skoultchi AI (1999)
Direct interaction of hematopoietic transcription factors PU.1
and GATA-1: functional antagonism in erythroid cells. Genes
Dev 13: 1398–1411
Ruffell D, Mourkioti F, Gambardella A, Kirstetter P, Lopez RG,
Rosenthal N, Nerlov C (2009) A CREB-C/EBPbeta cascade in-
duces M2 macrophage-speciﬁc gene expression and promotes
muscle injury repair. Proc Natl Acad Sci USA 106: 17475–17480
Spyropoulos DD, Pharr PN, Lavenburg KR, Jackers P, Papas TS,
Ogawa M, Watson DK (2000) Hemorrhage, impaired hematopoi-
esis, and lethality in mouse embryos carrying a targeted disrup-
tion of the Fli1 transcription factor. Mol Cell Biol 20: 5643–5652
Starck J, Cohet N, Gonnet C, Sarrazin S, Doubeikovskaia Z,
Doubeikovski A, Verger A, Duterque-Coquillaud M, Morle F
(2003) Functional cross-antagonism between transcription factors
FLI-1 and EKLF. Mol Cell Biol 23: 1390–1402
Starck J, Weiss-Gayet M, Gonnet C, Guyot B, Vicat JM, Morle F
(2010) Inducible Fli-1 gene deletion in adult mice modiﬁes several
myeloid lineage commitment decisions and accelerates prolifera-
tion arrest and terminal erythrocytic differentiation. Blood 116:
4795–4805
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL,
Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES,
Mesirov JP (2005) Gene set enrichment analysis: a knowledge-
based approach for interpreting genome-wide expression proﬁles.
Proc Natl Acad Sci USA 102: 15545–15550
Sugiyama D, Tanaka M, Kitajima K, Zheng J, Yen H, Murotani T,
Yamatodani A, Nakano T (2008) Differential context-dependent
effects of friend of GATA-1 (FOG-1) on mast-cell development and
differentiation. Blood 111: 1924–1932
Ting CN, Olson MC, Barton KP, Leiden JM (1996) Transcription
factor GATA-3 is required for development of the T-cell lineage.
Nature 384: 474–478
Tong Q, Tsai J, Tan G, Dalgin G, Hotamisligil GS (2005) Interaction
between GATA and the C/EBP family of transcription factors is
critical in GATA-mediated suppression of adipocyte differentia-
tion. Mol Cell Biol 25: 706–715
Tsai SF, Strauss E, Orkin SH (1991) Functional analysis and
in vivo footprinting implicate the erythroid transcription factor
GATA-1 as a positive regulator of its own promoter. Genes Dev 5:
919–931
Tsang AP, Fujiwara Y, Hom DB, Orkin SH (1998) Failure of mega-
karyopoiesis and arrested erythropoiesis in mice lacking the
GATA-1 transcriptional cofactor FOG. Genes Dev 12: 1176–1188
Urbanek P, Wang ZQ, Fetka I, Wagner EF, Busslinger M (1994)
Complete block of early B cell differentiation and altered pattern-
ing of the posterior midbrain in mice lacking Pax5/BSAP. Cell 79:
901–912
Yamaguchi Y, Nishio H, Kishi K, Ackerman SJ, Suda T (1999)
C/EBPbeta and GATA-1 synergistically regulate activity of the
eosinophil granule major basic protein promoter: implication for
C/EBPbeta activity in eosinophil gene expression. Blood 94:
1429–1439
Yeamans C, Wang D, Paz-Priel I, Torbett BE, Tenen DG, Friedman
AD (2007) C/EBPalpha binds and activates the PU.1 distal
enhancer to induce monocyte lineage commitment. Blood 110:
3136–3142
Zhang P, Behre G, Pan J, Iwama A, Wara-Aswapati N, Radomska
HS, Auron PE, Tenen DG, Sun Z (1999) Negative cross-talk
between hematopoietic regulators: GATA proteins repress PU.1.
Proc Natl Acad Sci USA 96: 8705–8710
Zhang P, Iwasaki-Arai J, Iwasaki H, Fenyus ML, Dayaram T,
Owens BM, Shigematsu H, Levantini E, Huettner CS, Lekstrom-
Himes JA, Akashi K, Tenen DG (2004) Enhancement of hemato-
poietic stem cell repopulating capacity and self-renewal in the
absence of the transcription factor C/EBP alpha. Immunity 21:
853–863
FOG-1 and GATA-1 in lineage commitment
E Mancini et al
&2012 European Molecular Biology Organization The EMBO Journal VOL 31 | NO 2 | 2012 365